reports honoraria and/or consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Mochida, Novartis and Novo Nordisk
GLP-1s come with a high rate of side effects, which we will need to become skilled at avoiding and treating
This $298 test (available after your first month of PlexusDx treatment) reveals your individual peptide pathway predispositions, allowing providers to anticipate medication sensitivities and optimize your semaglutide injection dose and timing strategy
When you eat less, you may feel more fatigued or sluggish due to insufficient nutrition
Wherfe insurance coverage for GLP-1 agonists lacks, alternative medications can suffice for weight maintenance
Does not revert without treatment